zedie.org
FDA Panel Endorses Endoxaban as Fourth NOAC
Edoxaban (Savaysa) should be approved for stroke and systemic embolism prevention in nonvalvular atrial fibrillation, an FDA advisory panel recommended Thursday. The panel voted 9-1 in favor of app…
